Reduced ethanol consumption by mice treated orally with arachidonic acid alone or in combination with the benign yeast Saccharomyces cerevisiae
Alcohol and Alcoholism · 13.05.2026 · 61 (4)
DOI: 10.1093/alcalc/agag046 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol and Alcoholism, online erschienen am 24.06.2026. Verfasst von Andrew W Day und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical Sciences, Tufts University, 150 Harrison Ave., Boston, MA 02111, United States. Hauptthemen laut MEDLINE: Arachidonic Acid, Saccharomyces cerevisiae, Alcohol Drinking, Ethanol. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Tufts Initiative on Substance Use and Addiction, NIAID NIH HHS.
Abstract (Originalsprache)
Aims
The goal of this study was to determine the effect of administering arachidonic acid (ARA) with or without the yeast Saccharomyces cerevisiae, on voluntary ethanol consumption by mice.
Methods
Ethanol consumption was measured using a continuous access two-bottle choice experiment with water and 15% ethanol (vol/vol). Ethanol naïve C57BL/6J mice were orally inoculated with ARA (or acidic PBS as the control), S. cerevisiae, or both each evening for three evenings. Ethanol consumption and preference were measured on the following days. In additional experiments, male and female mice underwent chronic intermittent exposure to ethanol vapor. After a 2-week exposure protocol, these mice were given access to 15% ethanol (vol/vol) via a two-bottle choice and inoculated nightly with ARA and S. cerevisiae (or acidic PBS and mock as the control). Results and conclusions Administration of ARA initially reduced ethanol preference and consumption by ethanol naïve female mice but the effects waned. In contrast, administration of ARA together with a fungus had a sustained effect that reduced preference and consumption. The effects of ARA and fungi were statistically significantly different from ARA alone on Day 3 of ethanol access. Chronically exposed mice that showed low initial consumption of ethanol in the two-bottle choice maintained low consumption when administered ARA and S. cerevisiae. These findings support the future development of a therapeutic regimen utilizing ARA and yeast, or targeting eicosanoids, that could be developed as a supplement to current approaches to reduce ethanol consumption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Biomedical Sciences, Tufts University, 150 Harrison Ave., Boston, MA 02111, United States.
- Department of Molecular Biology and Microbiology, Tufts University, 150 Harrison Ave., Boston, MA 02111, United States.
- Tonix Pharmaceuticals, Frederick, MD, United States.
- Department of Neuroscience, Tufts University, 150 Harrison Ave., Boston, MA 02111, United States.
Förderung
- NIH HHS
- Tufts Initiative on Substance Use and Addiction
- NIAID NIH HHS
- NIAAA NIH HHS
- NIDCR NIH HHS
- National Institutes of Health
Zitieren
APA
Day, A. W., Blandino, K., Hayes, E., Maguire, J., & Kumamoto, C. A. (2026). Reduced ethanol consumption by mice treated orally with arachidonic acid alone or in combination with the benign yeast Saccharomyces cerevisiae. Alcohol and Alcoholism, 61(4). https://doi.org/10.1093/alcalc/agag046
Vancouver
Day AW, Blandino K, Hayes E, Maguire J, Kumamoto CA. Reduced ethanol consumption by mice treated orally with arachidonic acid alone or in combination with the benign yeast Saccharomyces cerevisiae. Alcohol and Alcoholism. 2026;61(4). doi:10.1093/alcalc/agag046
BibTeX
@article{Day2026,
author = {Day, Andrew W and Blandino, Katrina and Hayes, Emma and Maguire, Jamie and Kumamoto, Carol A},
title = {Reduced ethanol consumption by mice treated orally with arachidonic acid alone or in combination with the benign yeast Saccharomyces cerevisiae},
journal = {Alcohol and Alcoholism},
year = {2026},
volume = {61},
number = {4},
doi = {10.1093/alcalc/agag046}
}
EUVIMED